User profiles for Tamara S Rodrigues
 | Tamara Silva RodriguesUSP Ribeirão Preto Verified email at usp.br Cited by 1380 |
[HTML][HTML] Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients
TS Rodrigues, KSG de Sá, AY Ishimoto… - Journal of Experimental …, 2021 - rupress.org
Severe cases of COVID-19 are characterized by a strong inflammatory process that may
ultimately lead to organ failure and patient death. The NLRP3 inflammasome is a molecular …
ultimately lead to organ failure and patient death. The NLRP3 inflammasome is a molecular …
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial
Objective To evaluate whether the addition of colchicine to standard treatment for COVID-19
results in better outcomes. Design We present the results of a randomised, double-blinded, …
results in better outcomes. Design We present the results of a randomised, double-blinded, …
Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection
…, ALN da Silva, TS Rodrigues, S Oliveira… - Science …, 2022 - science.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces mild or asymptomatic
COVID-19 in most cases, but some patients develop an excessive inflammatory process …
COVID-19 in most cases, but some patients develop an excessive inflammatory process …
Inflammasome activation by SARS-CoV-2 and its participation in COVID-19 exacerbation
TS Rodrigues, DS Zamboni - Current Opinion in Immunology, 2023 - Elsevier
Highlights • SARS-CoV-2 infection in vitro triggers activation of the NLRP3 inflammasome. •
The NLRP3 is activated in mice infected with SARS-CoV-2 and in the lungs of COVID-19 …
The NLRP3 is activated in mice infected with SARS-CoV-2 and in the lungs of COVID-19 …
Leishmania RNA virus exacerbates Leishmaniasis by subverting innate immunity via TLR3-mediated NLRP3 inflammasome inhibition
…, MVG da Silva, M Dilucca, TS Rodrigues… - Nature …, 2019 - nature.com
Leishmania RNA virus (LRV) is an important virulence factor associated with the development
of mucocutaneous Leishmaniasis, a severe form of the disease. LRV-mediated disease …
of mucocutaneous Leishmaniasis, a severe form of the disease. LRV-mediated disease …
Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells
ACG Salina, D Dos-Santos, TS Rodrigues… - Elife, 2022 - elifesciences.org
COVID-19 is a disease of dysfunctional immune responses, but the mechanisms triggering
immunopathogenesis are not established. The functional plasticity of macrophages allows …
immunopathogenesis are not established. The functional plasticity of macrophages allows …
Gasdermin-D activation promotes NLRP3 activation and host resistance to Leishmania infection
KSG de Sá, LA Amaral, TS Rodrigues… - Nature …, 2023 - nature.com
Intracellular parasites from the Leishmania genus cause Leishmaniasis, a disease affecting
millions of people worldwide. NLRP3 inflammasome is key for disease outcome, but the …
millions of people worldwide. NLRP3 inflammasome is key for disease outcome, but the …
Beneficial effects of colchicine for moderate to severe COVID-19: an interim analysis of a randomized, double-blinded, placebo controlled clinical trial
…, FP Veras, A Schneider, TS Rodrigues… - MedRxiv, 2020 - medrxiv.org
Introduction Neutrophilia and high levels of proinflammatory cytokines and other mediators
of inflammation are common finds in patients with severe acute respiratory syndrome due to …
of inflammation are common finds in patients with severe acute respiratory syndrome due to …
Inflammasome activation in COVID-19 patients
Severe cases of COVID-19 are characterized by a strong inflammatory process that may
ultimately lead to organ failure and patient death. The NLRP3 inflammasome is a molecular …
ultimately lead to organ failure and patient death. The NLRP3 inflammasome is a molecular …
Casp4/11 contributes to Nlrp3 activation and covid-19 exacerbation
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection triggers activation
of the NLRP3 inflammasome, which promotes inflammation and aggravates severe COVID-…
of the NLRP3 inflammasome, which promotes inflammation and aggravates severe COVID-…
